Issue 25 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

25

June 24, 2005Jun 24, 2005

Free

DOWNLOAD THE PDF

Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say.

FDA orders “limited distribution” for lung cancer drug Iressa.

House approves $210 million for Dept. of Defense cancer research programs.

House Committee on Appropriations approves $28.5 billion for NIH.

House panel investigating NIH handling of tissue specimens.

Recent Issues

Volume 52 | Issue 05 - February 06, 2026

Volume 52 | Issue 04 - January 30, 2026

Volume 52 | Issue 03 - January 23, 2026

Volume 52 | Issue 02 - January 16, 2026

Volume 52 | Issue 1 - January 09, 2026

Volume 51 | Issue 46 - December 19, 2025